Assembly Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary

• Assembly Biosciences Inc ASMB.OQ reported a quarterly adjusted loss of $1.33​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.98. The mean expectation of three analysts for the quarter was for a loss of $1.36 per share. Wall Street expected results to range from $-1.54 to $-1.19 per share.

• Revenue rose 12.8% to $9.63 million from a year ago; analysts expected $6.26 million.

• Assembly Biosciences Inc's reported EPS for the quarter was a loss of $1.33​.

• The company reported a quarterly loss of $10.2 million.

• Assembly Biosciences Inc shares had risen by 4.1% this quarter and gained 19.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 15% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Assembly Biosciences Inc is $31.00, about 39.2% above its last closing price of $18.86

This summary was machine generated from LSEG data August 6 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)